Research
September 1, 2020
UAMS’ Alan Tackett, Ph.D., Named to NIH Mechanisms of Cancer Therapeutics Study Section
Alan Tackett, Ph.D., was recently named a member of the National Institutes of Health (NIH) Mechanisms of Cancer Therapeutics-1 (MCT1) Study Section, one of the major review boards for evaluation of cancer research by the NIH Center for Scientific Review.
August 26, 2020
$10.6 Million Federal Grant to Expand National Proteomics Resource at UAMS
A $10.6 million grant from the National Institutes of Health (NIH) will allow the University of Arkansas for Medical Sciences (UAMS) to greatly expand its proteomics resource. This grant will establish the IDeA National Resource for Quantitative Proteomics as the first NIH National Resource in Arkansas, which will serve biomedical researchers across the entire nation.
August 24, 2020
UAMS Researchers See 43% Funding Increase in FY2020
LITTLE ROCK – The University of Arkansas for Medical Sciences (UAMS) and its affiliate research institutions saw research funding grow by 43% this past year, with $158.1 million in grants by the end of the fiscal year, June 30. The bulk of the funding is from the National Institutes of Health (NIH) and other federal…
July 24, 2020
Grant Gives UAMS Physician-Scientist Access to Gene Analysis Software
New grant funding will assist UAMS physician-scientist Analiz Rodriguez, M.D., Ph.D., in identifying more effective therapies for patients whose cancer has spread to their brain.
July 23, 2020
Fenghuang “Frank” Zhan, M.D., Ph.D., Awarded Nearly $3.14 Million to Further Myeloma Research
LITTLE ROCK — Fenghuang “Frank” Zhan, M.D., Ph.D., Myeloma Center research director at the University of Arkansas for Medical Sciences (UAMS), has received two grants totaling almost $3.14 million to study the molecular genetics and drug resistance of multiple myeloma, the second-most common blood-related cancer. One grant from the U.S. Department of Defense provides $1.4…
July 21, 2020
National Cancer Database at UAMS Becomes U.S. Storehouse for COVID-19 Images
LITTLE ROCK — A national database for patient cancer images at UAMS will become the storage site for COVID-19 clinical images from across the United States and around the globe, including chest x-rays and CT scans of the body. This week, UAMS also became the first research institution to contribute de-identified images of COVID-19 to…
June 25, 2020
UAMS Cancer Institute Joins KIYATEC Clinical Study of Test to Predict Pre-Treatment, Patient-Specific Response to Ovarian Cancer Drugs
KIYATEC, Inc. today announced that the Winthrop P. Rockefeller Cancer Institute at the University of Arkansas for Medical Sciences (UAMS) has joined the growing roster of institutions participating in its 3D-PREDICT clinical study to validate the company’s test as a patient-specific predictor of response to recommended drug therapies for patients with ovarian cancer.
June 22, 2020
UAMS Part of International Effort to Build AI Platform for Cancer Research
LITTLE ROCK — The University of Arkansas for Medical Sciences (UAMS) will have a key role in a major international effort using artificial intelligence (AI) to teach computers at local research centers how to recognize cancer. UAMS has received a four-year grant of $894,074 as part of EuCanImage, a nearly $9 million cancer research project…
June 3, 2020
Findings on DNA Damage Repair Published by UAMS Cancer Researcher
A research team led by cancer researcher Justin Leung, Ph.D., at the University of Arkansas for Medical Sciences (UAMS) has uncovered the role of the protein RNF168 in DNA damage repair and shown how mutations of the protein affect people with a rare genetic condition.
May 6, 2020
UAMS Radiation Oncologist Awarded $1.86 Million National Cancer Institute Grant
A five-year grant of more than $1.86 million from the National Cancer Institute (NCI) to the University of Arkansas for Medical Sciences (UAMS) will fund research aimed at reducing long-term neurological damage caused by a common cancer treatment regimen.
Previous page Next page